Description
PT-141 / Oxytocin is a combination research solution pairing PT-141 (15mg), a cyclic heptapeptide melanocortin receptor agonist, with Oxytocin (2.5mg), a hypothalamic nonapeptide hormone. Researchers use it to study the two peptides together in receptor signaling research.
In rodent models and cultured cells, investigations have focused on melanocortin MC3 and MC4 receptor signaling, oxytocin receptor binding, and hypothalamic circuit mapping. Its paired composition makes it a useful probe for combined neuropeptide receptor research.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.